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Many common voice disorders are chronic or recurring conditions that are likely to result 
from inefficient and/or abusive patterns of vocal behavior, referred to as vocal hyper-
function. The clinical management of hyperfunctional voice disorders would be greatly 
enhanced by the ability to monitor and quantify detrimental vocal behaviors during an 
individual’s activities of daily life. This paper provides an update on ongoing work that 
uses a miniature accelerometer on the neck surface below the larynx to collect a large 
set of ambulatory data on patients with hyperfunctional voice disorders (before and 
after treatment) and matched-control subjects. Three types of analysis approaches are 
being employed in an effort to identify the best set of measures for differentiating among 
hyperfunctional and normal patterns of vocal behavior: (1) ambulatory measures of voice 
use that include vocal dose and voice quality correlates, (2) aerodynamic measures 
based on glottal airflow estimates extracted from the accelerometer signal using sub-
ject-specific vocal system models, and (3) classification based on machine learning and 
pattern recognition approaches that have been used successfully in analyzing long-term 
recordings of other physiological signals. Preliminary results demonstrate the potential 
for ambulatory voice monitoring to improve the diagnosis and treatment of common 
hyperfunctional voice disorders.
Keywords: voice monitoring, accelerometer, vocal function, voice disorders, vocal hyperfunction, glottal inverse 
filtering, machine learning
inTrODUcTiOn
Voice disorders have been estimated to affect approximately 30% of the adult population in the 
United States at some point in their lives, with 6.6–7.6% of individuals affected at any given point 
in time (Roy et al., 2005; Bhattacharyya, 2014). While many vocally healthy speakers take verbal 
communication for granted, individuals suffering from voice disorders experience significant 
communication disabilities with far-reaching social, professional, and personal consequences 
(NIDCD, 2012).
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Normal voice sounds are produced in the larynx by rapid air 
pulses that are emitted as the vocal cords (folds) are driven into 
vibration by exhaled air from the lungs. Disturbances in voice 
production (i.e., voice disorders) can be caused by a variety 
of conditions that affect how the larynx functions to generate 
sound, including (1) neurological disorders of the central 
(Parkinson’s disease, stroke, etc.) or peripheral (e.g., damage to 
laryngeal nerves causing vocal fold paresis/paralysis) nervous 
system; (2) congenital (e.g., restrictions in normal development 
of laryngeal/airway structures) or acquired organic (laryngeal 
cancer, trauma, etc.) disorders of the larynx and/or airway; and 
(3) behavioral disorders involving vocal abuse/misuse that may 
or may not cause trauma to vocal fold tissue (e.g., nodules). The 
most frequently occurring subset of voice disorders is associated 
with vocal hyperfunction, which refers to chronic “conditions of 
abuse and/or misuse of the vocal mechanism due to excessive 
and/or ‘imbalanced’ [uncoordinated] muscular forces” (Hillman 
et  al., 1989, p. 373). Over the years, our group has begun to 
provide evidence for the concept that there are two types of 
vocal hyperfunction that can be quantitatively described and dif-
ferentiated from each other and normal voice production using 
a combination of acoustic and aerodynamic measures (Hillman 
et al., 1989, 1990).
Phonotraumatic vocal hyperfunction (previously termed 
adducted hyperfunction) is associated with the formation of 
benign vocal fold lesions  –  such as nodules and polyps. Vocal 
fold nodules or polyps are believed to develop as a reaction to 
persistent tissue inflammation, chronic cumulative vocal fold 
tissue damage, and/or environmental influences (Titze et  al., 
2003; Czerwonka et  al., 2008; Karkos and McCormick, 2009). 
Once formed, these lesions may prevent adequate vocal fold 
contact/closure that reduces the efficiency of sound production 
and can cause individuals to compensate by increasing muscular 
and aerodynamic forces. This compensatory behavior may result 
in further tissue damage and become habitual due to the need 
to constantly maintain functional voice production during daily 
life in the presence of a vocal fold pathology. By contrast, non-
phonotraumatic vocal hyperfunction (previously termed non-
adducted hyperfunction)  –  often diagnosed as muscle tension 
dysphonia (MTD) or functional dysphonia – is associated with 
symptoms such as vocal fatigue, excessive intrinsic/extrinsic neck 
muscle tension and discomfort, and voice quality degradation in 
the absence of vocal fold tissue trauma. There can be a wide range 
of voice quality disturbances (e.g., various degrees of strain or 
breathiness) whose nature and severity can display significant 
situational variation, such as variation associated with changes in 
levels of emotional stress throughout the course of a day (Hillman 
et al., 1990). MTD can be triggered by a variety of conditions/
circumstances, including psychological conditions (traumatizing 
events, emotional stress, etc.), chronic irritation of the laryngeal 
and/or pharyngeal mucosa (e.g., laryngopharyngeal reflux), and 
habituation of maladaptive behaviors, such as persistent dyspho-
nia following resolution of an upper respiratory infection (Roy 
and Bless, 2000).
To assess the prevalence and persistence of hyperfunctional 
vocal behaviors during diagnosis and management, clinicians 
currently rely on patient self-report and self-monitoring, which 
are highly subjective and prone to be unreliable. In addition, 
investigators have studied clinician-administered perceptual 
ratings of voice quality and endoscopic imaging and the quan-
titative analysis of objective measures derived from acoustics, 
electroglottography, imaging, and aerodynamic voice signals 
(Roy et  al., 2013). Among work that sought to automatically 
detect voice disorders, including vocal hyperfunction, acoustic 
analysis approaches have employed neural maps (Hadjitodorov 
et al., 2000), non-linear measures (Little et al., 2007), and voice 
source-related properties (Parsa and Jamieson, 2000) from 
snapshots of phonatory recordings obtained during a single 
laboratory session. Because hyperfunctional voice disorders are 
associated with daily behavior, the diagnosis and treatment of 
these disorders may be greatly enhanced by the ability to unob-
trusively monitor and quantify vocal behaviors as individuals go 
about their normal daily activities. Ambulatory voice monitoring 
may enable clinicians to better assess the role of vocal behaviors 
in the development of voice disorders, precisely pinpoint the 
location and duration of abusive and/or maladaptive behaviors, 
and objectively assess patient compliance with the goals of voice 
therapy.
This paper reports on our ongoing investigation into the use of 
a miniature accelerometer on the neck surface below the larynx to 
acquire and analyze a large set of ambulatory data from patients 
with hyperfunctional voice disorders (before and after treatment 
stages) as compared to matched-control subjects. We have previ-
ously reported on our development of a user-friendly and flexible 
platform for voice health monitoring that employs a smartphone 
as the data acquisition platform connected to the accelerometer 
(Mehta et al., 2012b, 2013). The current report extends on that 
pilot work and describes data acquisition protocols, as well as 
initial results from three analysis approaches: (1) existing ambu-
latory measures of voice use, (2) aerodynamic measures based on 
glottal airflow estimates extracted from the accelerometer signal, 
and (3) classification based on machine learning and pattern 
recognition techniques. Although the methodologies of these 
analysis approaches largely have been published, the novel contri-
butions of the current paper include ambulatory voice measures 
from the largest cohort of speakers to date (142 subjects), initial 
estimation of ambulatory glottal airflow properties, and updated 
machine learning results for the classification of 51 speakers with 
phonotraumatic vocal hyperfunction from matched-control 
speakers.
MaTerials anD MeThODs
This section describes subject recruitment, data acquisition 
protocols, and the three analysis approaches of existing voice 
use measures, aerodynamic parameter estimation, and machine 
learning to aid in the classification of hyperfunctional vocal 
behaviors.
subject recruitment
Informed consent was obtained from all the subjects participat-
ing in this study, and all experimental protocols were approved 
by the institutional review board of Partners HealthCare System 
at Massachusetts General Hospital.
TaBle 1 | Occupations of adult females with phonotraumatic vocal 
hyperfunction and matched-control participants analyzed (51 pairs).
Occupation no. of subject pairs Patient diagnosis
Singer 37 Nodules (32)
Polyp (5)
Teacher 5 Nodules
Consultant 2 Nodules (1)
Polyp (1)
Psychotherapist/psychologist 2 Nodules
Recruiter 2 Nodules
Marketer 1 Nodules
Media relations 1 Nodules
Registered nurse 1 Polyp
Diagnoses for the patient group are also listed for each occupation.
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Two groups of individuals with voice disorders are being 
enrolled in the study: patients with phonotraumatic vocal 
hyperfunction (vocal fold nodules or polyps) and patients with 
non-phonotraumatic vocal hyperfunction (MTD). Diagnoses 
are based on a complete team evaluation by laryngologists and 
speech-language pathologists at the Massachusetts General 
Hospital Voice Center that includes (1) a complete case history, 
(2) endoscopic imaging of the larynx (Mehta and Hillman, 2012), 
(3) aerodynamic and acoustic assessment of vocal function (Roy 
et  al., 2013), (4) patient-reported voice-related quality of life 
(V-RQOL) questionnaire (Hogikyan and Sethuraman, 1999), 
and (5) clinician-administered consensus auditory-perceptual 
evaluation of voice (CAPE-V) assessment (Kempster et  al., 
2009).
Matched-control groups are obtained for each of the two 
patient groups. Each patient typically aids in identifying a work 
colleague of the same gender and approximate age (±5 years) who 
has a normal voice. The normal vocal status of all control subjects 
is verified via interview and a laryngeal stroboscopic examina-
tion. Each control subject is monitored for one full 7-day week.
Figure 1 displays the treatment sequences (tracks) and time 
points at which patients in the study are monitored for a full week. 
Patients with phonotraumatic vocal hyperfunction may follow 
one of three usual treatment tracks (Figure 1A). The particular 
treatment track chosen depends upon clinical management deci-
sions regarding surgery or voice therapy. In Track A, individuals 
are monitored before and after successful voice therapy and do 
not need surgical intervention (therapy may involve sessions 
spanning several weeks or months). In Track B, patients initially 
attempt voice therapy but subsequently require surgical removal 
of their vocal fold lesion(s) to attain a more satisfactory vocal 
outcome; a second round of voice therapy is then typically 
required to retrain the vocal behavior of these patients to prevent 
the recurrence of vocal fold lesions. In Track C, patients undergo 
surgery first followed by voice therapy. Finally, patients with 
non-phonotraumatic vocal hyperfunction typically follow one 
treatment track and thus are monitored for 1 week before and 
after voice therapy (Figure 1B).
Data collection is ongoing, as Figure 1 lists patient enrollment 
along with the number of vocally healthy speakers who have 
been able to be recruited to be matched to a patient. For an initial 
analysis of a complete data set, results are presented for patients 
with available data from matched-control subjects. In addition, 
because the prevalence of these types of voice disorders is much 
higher in females (hence, more data acquired from female 
subjects) and to eliminate the impact on the analysis of known 
differences between male and female voice characteristics (such 
as fundamental frequency), only female subject data were of focus 
in the current report.
Table 1 lists the occupations and diagnoses of the 51 female 
participants with phonotraumatic vocal hyperfunction in the 
study who have been paired with matched-control subjects (there 
were only 4 male subject pairs). All participants were engaged in 
occupations considered to be at a higher-than-normal risk for 
developing a voice disorder. The majority of patients (37) were 
professional, amateur, or student singers; every effort was made 
to match singers with control subjects in a similar musical genre 
(classical or non-classical) to account for any genre-specific vocal 
behaviors. Forty-four patients were diagnosed with vocal fold 
nodules, and seven patients had a unilateral vocal fold polyp. The 
average (SD) age of participants within the group was 24.4 (9.1) 
years.
Table 2 lists the occupations of the 20 female participants with 
non-phonotraumatic vocal hyperfunction in the study who have 
been paired with matched-control subjects (there were 6 male 
subject pairs). All patients were diagnosed with MTD and did 
not exhibit vocal fold tissue trauma. The average (SD) age of 
participants within the patient group was 41.8 (15.4) years.
FigUre 1 | Treatment tracks for patients exhibiting (a) 
phonotraumatic and (B) non-phonotraumatic hyperfunctional vocal 
behaviors. Week numbers (W1, W2, W3, and W4) refer to time points during 
which ambulatory monitoring of voice use is being acquired using the 
smartphone-based voice health monitor. The current enrollment of each 
patient and matched-control pairing is listed above each week number.
TaBle 2 | Occupations of adult females with non-phonotraumatic vocal 
hyperfunction and matched-control participants analyzed (20 pairs).
Occupation no. of subject pairs
Registered nurse 3
Singer 3
Teacher 3
Administrator 2
At-home caregiver 2
Student 2
Social worker 1
Actress 1
Administrative assistant 1
Exercise instructor 1
Systems analyst 1
All patients were diagnosed with muscle tension dysphonia.
FigUre 2 | in-laboratory data acquisition setup. (a) Synchronized 
recordings are made of signals from an acoustic microphone (MIC), 
electroglottography electrodes (EGG), accelerometer sensor (ACC), 
high-bandwidth oral airflow (FLO), and intraoral pressure (PRE). (B) Signal 
snapshot of a string of “pae” tokens required for the estimation of subglottal 
pressure and airflow during phonation. © 2013 IEEE. Reprinted, with 
permission, from Mehta et al. (2013).
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Data acquisition Protocol
Prior to in-field ambulatory voice monitoring, subjects are 
assessed in the laboratory to document their vocal status and 
record signals that enable the calibration of the accelerometer 
signal for input to the vocal system model that is used to estimate 
aerodynamic parameters.
In-Laboratory Voice Assessment
Figure 2A illustrates the in-laboratory multisensor setup consist-
ing of the simultaneous acquisition of data from the following 
devices:
 (1) Acoustic microphone placed 10 cm from the lips (MKE104, 
Sennheiser, Electronic GmbH, Wennebostel, Germany).
 (2) Electroglottograph electrodes placed across the thyroid car-
tilage to measure time-varying laryngeal impedance (EG-2, 
Glottal Enterprises, Syracuse, NY, USA).
 (3) Accelerometer placed on the neck surface at the base of the 
neck (BU-27135; Knowles Corp., Itasca, IL, USA).
 (4) Airflow sensor collecting high-bandwidth aerodynamic 
data via a circumferentially vented pneumotachograph face 
mask (PT-2E, Glottal Enterprises).
 (5) Low-bandwidth air pressure sensor connected to a narrow 
tube inserted through the lips in the mouth (PT-25, Glottal 
Enterprises).
In particular, the use of the pneumotachograph mask to 
acquire the high-bandwidth oral airflow signal is a key step in 
calibrating/adjusting the vocal system model described in Section 
“Estimating Aerodynamic Properties from the Accelerometer 
Signal” so that aerodynamic parameters can be extracted from 
the accelerometer signal (Zañartu et al., 2013). All subjects wore 
the accelerometer below the level of the larynx (subglottal) on the 
front of the neck just above the sternal notch. When recorded from 
this location, the accelerometer signal of an unknown phrase is 
unintelligible. The accelerometer sensor used is relatively immune 
to environmental sounds and produces a voice-related signal 
that is not filtered by the vocal tract, alleviating confidentiality 
concerns because speech audio is not recorded.
The in-laboratory protocol requires subjects to perform the 
following speech tasks at a comfortable pitch in their typical 
speaking voice mode:
 (1) three cardinal vowels (“ah,” “ee,” “oo”) sustained at soft, 
comfortable, and loud levels;
 (2) first paragraph of the Rainbow Passage at a comfortable 
loudness level;
 (3) string of consonant-vowel pairs (e.g., “pae pae pae pae pae”).
The sustained vowels provide data for computing objective 
voice quality metrics such as perturbation measures, harmonics-
to-noise ratio, and harmonic spectral tilt. The Rainbow Passage 
is a standard phonetically balanced text that has been frequently 
used in voice and speech research (Fairbanks, 1960). The string 
of /pae/ syllables is designed to enable non-invasive, indirect 
estimates of lung pressure (during lip closure for the /p/ when 
airway pressure reaches a steady state/equilibrates) and laryngeal 
airflow (during vowel production when the airway is not con-
stricted) for a sustained vowel (Rothenberg, 1973). Figure  2B 
FigUre 3 | ambulatory voice health monitor: (a) smartphone, 
accelerometer sensor, and cable with interface circuit encased in 
epoxy; (B) the wired accelerometer mounted on a silicone pad affixed 
to the neck midway between the adam’s apple and V-shaped notch 
of the collarbone. © 2013 IEEE. Reprinted, with permission, from Mehta 
et al. (2013X).
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displays a snapshot of synchronized in-laboratory waveforms 
from the consonant-vowel task for a 28-year-old female music 
teacher diagnosed with vocal fold nodules.
In-Field Ambulatory Monitoring of Voice Use
In the field, an Android smartphone (Nexus S; Samsung, Seoul, 
South Korea) provides a user-friendly interface for voice monitor-
ing, daily sensor calibration, and periodic collection of subject 
responses to queries about their vocal status (Mehta et al., 2012b). 
The smartphone contains a high-fidelity audio codec (WM8994; 
Wolfson Microelectronics, Edinburgh, Scotland, UK) that records 
the accelerometer signal using sigma-delta modulation (128× over-
sampling) at a sampling rate of 11 025 Hz. Of critical importance, 
operating system root access allows for control over audio settings 
related to highpass filtering and programmable gain arrays prior 
to analog-to-digital conversion. By default, highpass filter cutoff 
frequencies are typically set above 100 Hz to optimize cellphone 
audio quality and remove low-frequency noise due to wind noise 
and/or mechanical vibration. These cutoff frequencies undesirably 
affect frequencies of interest through spectral shaping and phase 
distortion; thus, for the current application, the highpass filter 
cutoff frequency is modified to a high-fidelity setting of 0.9  Hz. 
Smartphone rooting also enables setting the analog gain to maxi-
mize signal quantization; e.g., the WM8994 audio codec gain values 
can be set between −16.5 dB and +30.0 dB in increments of 1.5 dB.
Figure 3 displays the smartphone-based voice health monitor 
system. Each morning, subjects affix the accelerometer – encased 
in epoxy and mounted on a soft silicone pad  –  to their neck 
halfway between the thyroid prominence and the suprasternal 
notch using hypoallergenic double-sided tape (Model 2181, 3M, 
Maplewood, MN, USA). Smartphone prompts then lead the 
subject through a brief calibration sequence that maps the accel-
erometer signal amplitude to acoustic sound pressure level (Švec 
et  al., 2005). Subjects produce three “ah” vowels from a soft to 
loud (or loud to soft) level that are used to generate a linear regres-
sion between acceleration amplitude and microphone signal level 
(decibel–decibel plot) so that the uncalibrated acceleration level 
can be converted to units of dB SPL (dB re 20 μPa). The acoustic 
signal is recorded using a handheld audio recorder (H1 Handy 
Recorder, Zoom Corporation, Tokyo, Japan) at a distance of 
15 cm to the subject’s lips. The microphone is not needed the rest 
of the day.
With the smartphone placed in the pocket or worn in a belt 
holster, subjects engage in their typical daily activities at work 
and home and are able to pause data acquisition during activi-
ties that could damage the system, such as exercise, swimming, 
showering, etc. The smartphone application requires minimal 
user interaction during the day. Every 5 h, users are prompted to 
respond to three questions related to vocal effort, discomfort, and 
fatigue (Carroll et al., 2006):
 (1) Effort: say “ahhh” softly at a pitch higher than normal. Then 
say “ha ha ha ha ha” in the same way. Rate how difficult the 
task was.
 (2) Discomfort: what is your current level of discomfort when 
talking or singing?
 (3) Fatigue: what is your current level of voice-related fatigue 
when talking or singing?
The three questions are answered using slider bars on the 
smartphone ranging from 0 (no presence of effort, discomfort, or 
fatigue) to 100 (maximum effort, discomfort, or fatigue).
At the end of the day, the accelerometer is removed, recording 
is stopped, and the smartphone is charged as the subject sleeps. 
A brief daily email survey asks subjects about when their work/
school day began and ended and if anything atypical occurred 
during the day.
Voice Quality and Vocal  
Dose Measures
Voice-related parameters for voice disorder classification fall 
into the following two categories: (1) time-varying trajectories 
of features that are computed on a frame-by-frame basis and (2) 
measures of voice use that accumulate frame-based metrics over 
a given duration (i.e., vocal dose measures). These measures may 
be computed offline in a post hoc analysis of data or online on the 
smartphone for real-time display or biofeedback.
Table 3 describes the suite of current frame-based parameters 
computed over 50-ms, non-overlapping frames. These modifi-
able frame settings currently mimic the default behavior of the 
Ambulatory Phonation Monitor (KayPENTAX, Montvale, NJ, 
USA) and strike a practical balance between the requirement 
of real-time computation and capture of temporal and spectral 
voice characteristics during time-varying speech production. 
The parameters quantify signal properties related to amplitude, 
frequency, periodicity, spectral tilt, and cepstral harmonicity: SPL 
and f0 (Mehta et  al., 2012b), autocorrelation peak magnitude, 
harmonic spectral tilt (Mehta et al., 2011), low- to high-frequency 
spectral power ratio (LH ratio) (Awan et al., 2010), and cepstral 
peak prominence (CPP) (Mehta et al., 2012c). Figure 4A illus-
trates the computation of these measures from the time, spectral, 
and cepstral domains. In the past, we have set a priori thresholds 
on signal amplitude, fundamental frequency, and autocorrelation 
TaBle 3 | Description of frame-based signal features computed on in-field ambulatory voice data.
Feature Units Voicing criteria Description
Sound pressure level at 15 cm dB SPL 45–130 Acceleration amplitude mapped to acoustic sound pressure level (Švec et al., 2005)
Fundamental frequency Hz 70–1000 Reciprocal of first non-zero peak location in the normalized autocorrelation function (Mehta 
et al., 2012b)
Autocorrelation peak amplitude 0.60–1 Relative amplitude of first non-zero peak in the normalized autocorrelation function (Mehta 
et al., 2012b)
Subharmonic peak 0.25–1 Relative amplitude of a secondary peak, if it exists, located around half way to the 
autocorrelation peak
Harmonic spectral tilt dB/
octave
−25–0 Linear regression slope over the first 8 spectral harmonics (Mehta et al., 2011)
Low-to-high spectral ratio dB 22–50 Difference between spectral power below and above 2000 Hz (Awan et al., 2010)
Cepstral peak prominence dB 10–35 Magnitude of the highest peak in the power cepstrum (Mehta et al., 2012c)
Zero crossing rate 0–1 Proportion of frame that signal crosses its mean
FigUre 4 | Parameterization of the (a) original and (B) inverse-filtered waveforms from the oral airflow (black) and neck-surface acceleration (acc, 
red-dashed) waveform processed with subglottal impedance-based inverse filtering. Shown are the time waveform, frequency spectrum, and cepstrum, 
along with the parameterization of each domain to yield clinically salient measures of voice production.
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amplitudes to decide whether a frame contains voice activity or 
not (Mehta et al., 2012b). Since then, additional signal measures 
have been implemented to improve voice disorder classification 
and refine voice activity detection. Table 3 also reports the default 
ranges for each measure for a frame to be considered voiced.
The development of accumulated vocal dose measures (Titze 
et al., 2003) was motivated by the desire to establish safety thresholds 
regarding exposure of vocal fold tissue to vibration during phona-
tion, analogous to Occupational Safety and Health Administration 
guidelines for auditory noise and mechanical vibration exposure. 
The three most frequently used vocal dose measures to quantify 
accumulated daily voice use are phonation time, cycle dose, and 
distance dose. Phonation (voiced) time reflects the cumulative 
duration of vocal fold vibration, also expressed as a percentage of 
total monitoring time. The cycle dose is an estimate of the number 
of vocal fold oscillations during a given period of time. Finally, 
the distance dose estimates the total distance traveled by the vocal 
folds, combining cycle dose with vocal fold vibratory amplitude 
based on the estimates of acoustic sound pressure level.
Additionally, attempts were made to characterize vocal load and 
recovery time by tracking the occurrences and durations of con-
tiguous voiced and non-voiced segments. From these data, occur-
rence and accumulation histograms provide a summary of voicing 
and silence characteristics over the course of a monitored period 
(Titze et al., 2007). To further quantify vocal loading, smoothing 
was performed over the binary vector of voicing decisions such that 
contiguous voiced segments were connected if they were close to 
each other based on a given duration threshold (typically <0.5 s). 
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The derived contiguous segments approximate speech phrase seg-
ments produced on single breaths to begin to investigate respira-
tory factors in voice disorders (Sapienza and Stathopoulos, 1994).
Amplitude, frequency, and vocal dose features are tradition-
ally believed to be associated with phonotraumatic hyperfunc-
tional behaviors (e.g., talking loud, at an inappropriate pitch, or 
too much without enough voice rest) (Roy and Hendarto, 2005; 
Karkos and McCormick, 2009). However, our previous work 
demonstrated that overall average signal amplitude, fundamental 
frequency, and vocal dose measures were not different between 
35 patients with vocal fold nodules or polyps and their matched-
controls (Van Stan et  al., 2015b). The results provided in this 
manuscript replicate our previous findings with a larger group 
of 51 matched pairs and extend the analysis approach by (1) add-
ing novel measures related to voice quality and (2) completing 
novel comparisons among patients with non-phonotraumatic 
vocal hyperfunction versus matched controls and between both 
subtypes of patients with vocal hyperfunction.
estimating aerodynamic Properties from 
the accelerometer signal
Subglottal impedance-based inverse filtering (IBIF) is a biologi-
cally inspired acoustic transmission line model that allows for the 
estimation of glottal airflow from neck-surface acceleration 
(Zañartu et al., 2013). This vocal system model follows a lumped-
impedance parameter representation in the frequency domain 
using a series of concatenated T-equivalent segments of lumped 
acoustic elements that relate acoustic pressure to airflow. Each 
segment includes terms for representing key components for 
the subglottal system such as yielding walls (cartilage and soft 
tissue components), viscous losses, elasticity, and inertia. Then, a 
cascade connection is used to account for the acoustic transmis-
sion associated with the subglottal system based upon symmetric 
anatomical descriptions for an average male (Weibel, 1963). In 
addition, a radiation impedance is used to account for neck skin 
properties (Franke, 1951; Ishizaka et al., 1975) and accelerometer 
loading (Wodicka et al., 1989). The DC level of the airflow wave-
form is not modeled by IBIF due to the accelerometer waveform 
only being an AC signal. Thus, this overall approach provides an 
airflow-to-acceleration transfer function that is inverted when 
processing the accelerometer signal.
Subject-specific parameters need to be obtained to use sub-
glottal IBIF as a signal processing approach for the accelerometer 
signal. Five parameters are estimated for each subject  –  three 
parameters for the skin model (skin inertance, resistance, and 
stiffness) and two parameters for tracheal geometry (tracheal 
length and accelerometer position relative to the glottis). The most 
relevant parameter values are searched for using an optimization 
scheme that minimizes the mean-squared error between oral 
airflow–derived and neck-surface acceleration–derived glottal 
airflow waveforms. A default parameter set is fine tuned to a given 
subject by means of five scaling factors Qi with i = 1, … , 5, which 
are designed to be estimated from a stable vowel segment. Since 
the subglottal system is assumed to remain the same for all other 
conditions (loudness, vowels, etc.), the estimated Q parameters 
may only need to be obtained once for each subject.
The subglottal IBIF scheme was initially evaluated for con-
trolled scenarios that represented different glottal configurations 
and voice qualities in sustained vowel contexts (Zañartu et  al., 
2013). Under these conditions, a mean absolute error of <10% 
was observed for two glottal airflow measures of interest: maxi-
mum flow declination rate (MFDR) and the peak-to-peak glottal 
flow (AC Flow). Recently, the method was adapted for a real-time 
implementation in the context of ambulatory biofeedback (Llico 
et  al., 2015), but again tested and validated only in sustained 
vowel contexts. Therefore, an evaluation of the subglottal IBIF 
method under continuous speech conditions is a natural next 
step. Continuous speech is the scenario where subglottal IBIF has 
the most potential to contribute to the field of voice assessment, as 
it can provide aerodynamic measures in the context of an ambula-
tory assessment of vocal function.
In this paper, we provide an initial assessment of the perfor-
mance of the subglottal IBIF scheme for the phonetically balanced 
Rainbow Passage obtained in the laboratory, as well as for the 
data obtained from a weeklong recording in the field. Multiple 
measures of vocal function were extracted from each cycle and 
averaged over 50-ms frames (50% overlap), including AC Flow, 
MFDR, open quotient (OQ), speed quotient (SQ), spectral slope 
(H1–H2), and normalized amplitude quotient (NAQ). Figure 4 
illustrates the extraction of these measures from the inverse-
filtered acceleration waveform in the time and spectral domains. 
OQ is defined as tO/(tO +  tC), and SQ is defined as 100(top/tcp). 
NAQ is a measure of the closing phase and is defined as the ratio 
of AC Flow to MFDR normalized by the period duration (tO + tC) 
(Alku et al., 2002).
The in-laboratory voice assessment described in Section 
“In-Laboratory Voice Assessment” enables a direct comparison 
of the subglottal IBIF of neck-surface acceleration with vocal 
tract inverse-filtering of the oral airflow waveform. It is noted 
that inverse filtering of oral airflow for time-varying, continu-
ous speech segments is a topic of research unto itself, and there 
are no clear guidelines to best approach the problem. Thus, we 
selected a simple but clinically relevant method of oral airflow 
processing based on single formant inverse filtering (Perkell 
et  al., 1991) that has been used for the assessment of vocal 
function in speakers with and without voice disorders (Hillman 
et al., 1989; Perkell et al., 1994; Holmberg et al., 1995). Subglottal 
IBIF with a single set of Q parameters was used to estimate a 
continuous glottal airflow signal for each speaker’s ambulatory 
time series.
Machine learning and Pattern 
recognition approaches
Machine learning and pattern recognition approaches have 
become strong tools in the analysis of time series data. This has 
been particularly true in wireless health monitoring (Clifford 
and Clifton, 2012), where multiple levels of analysis are needed 
to abstract a clinically relevant diagnosis or state. Learning 
problems can be mapped onto a set of four general components: 
(1) choice of training data and evaluation method, (2) representa-
tion of examples (often called feature engineering), (3) choice of 
objective function and constraints, and (4) choice of optimization 
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method. Choosing these components should be dictated by the 
goal at hand and the type of data available.
We first considered the case of patients with phonotraumatic 
vocal hyperfunction prior to any treatment and their matched 
controls. Each subject (patient or control) had a week of ambula-
tory neck-surface acceleration data related to voice use. Previous 
work suggested that long-term averages of standard voice 
measures did not capture differences between patients with vocal 
fold nodules or polyps and their matched controls (Mehta et al., 
2012a). Thus we hypothesize that the tissue pathology (nodules or 
polyps) could create aggregate differences at the extremes of the 
recorded time series rather than at the averages. We had some ini-
tial success examining whether statistical features of fundamental 
frequency (f0) and SPL, such as skewness, kurtosis, 5th percentile, 
and 95th percentile, could capture this more extreme information 
and lead to an accurate patient classifier in our population.
Briefly, we first extracted SPL and f0 measures and voicing 
criteria described in Section “Voice Quality and Vocal Dose 
Measures” from 50-ms, non-overlapping frames. From these 
frames, we built 5-min, non-overlapping windows (i.e., 6000 
frames per window) over each day in a subject’s entire weeklong 
record. We then took univariate statistics of feature histograms 
and the cumulative vocal dose measures from windows contain-
ing at least 30 frames labeled as voiced (0.5% phonation time). 
Normalized versions of the statistics were obtained by converting 
each statistic into units of SD based on that feature’s baseline 
distribution over an average hour in the first half of the day. 
Additional methodological details are available in a previous 
publication (Ghassemi et al., 2014).
Here, a concatenated feature matrix represented each subject’s 
week. The features from each 5-min window were associated with 
a patient or control label and used to create an L1-regularized 
logistic regression using a least absolute shrinkage and selection 
operator (LASSO) model. The LASSO model was used to classify 
5-min windows from a held-out set of data from patient and con-
trol subjects. We used leave-one-out-cross-validation (LOOCV) 
to partition our dataset of 51 paired adult female subjects into 51 
training and test sets such that a single patient-control pair was 
the held-out test set at each of the 51 iterations. If more than a 
given proportion of the test subject’s windows were classified with 
a patient label, we predicted that subject as being a patient; other-
wise, the subject was classified as a normal control. Classification 
performance was evaluated across the 51 LASSO models by the 
proportion of the test set correctly predicted, as well as by the area 
under the receiver operating characteristic curve (AUC), F-score, 
sensitivity (correct labeling of patients), and specificity (correct 
labeling of controls).
resUlTs
Selected results from applying the three analysis approaches to 
the current data set of phonotraumatic and non-phonotraumatic 
vocal hyperfunction groups are reported as an initial demonstra-
tion of the potential discriminative performance and predictive 
power of these methods. Patients and their matched-control 
subjects continue to be enrolled and followed throughout their 
treatment stages.
summary statistics of Voice Quality and 
Vocal Dose Measures
Figure  5 illustrates a daylong voice use profile of a 34-year-old 
adult female psychologist prior to surgery for a left vocal fold polyp 
and right vocal fold reactive nodule. Phonation time for her day 
reached 20.3% with a mean (SD) SPL of 81.8 (6.4) dB SPL and f0 
mode (SD) of 194.5 (51.2) Hz. Such visualizations (made interac-
tive through navigable graphical user interfaces) of measures 
such those described in Section “Voice Quality and Vocal Dose 
Measures” may ultimately enable clinicians to identify certain 
patterns of voice features related to vocal hyperfunction and subse-
quently make informed decisions regarding patient management.
As an initial description of the pre-treatment patient data, 
summary statistics were computed from the weeklong time 
series of SPL, f0, voice quality features, and vocal dose measures. 
The 5th percentiles and 95th percentiles were used to compute 
minimum, maximum, and range statistics. A four-factor, one-way 
analysis of variance was carried out for each summary statistic 
in the comparison of the two patient groups and their respec-
tive matched-control groups. The between-group comparisons 
consisted of the phonotraumatic patients versus their matched 
controls (51 pairs), the non-phonotraumatic patients versus 
their matched controls (20 pairs), and the phonotraumatic group 
versus the non-phonotraumatic group.
Table  4 reports the group-based mean (SD) for voice use 
summary statistics of SPL, f0, and vocal dose measures for 
weeklong data collected from the phonotraumatic patient and 
matched-control groups and the non-phonotraumatic patient 
and matched-control groups. Based on a post hoc analysis, meas-
ures that exhibited statistically significant differences (p < 0.001) 
between the two patient groups and between patient and 
matched-control groups are highlighted. The table also reports 
voice quality summary statistics of the autocorrelation peak 
magnitude, harmonic spectral tilt, LH ratio, and CPP.
Individuals with vocal fold nodules or polyps exhibited statis-
tically significant differences compared to individuals with MTD 
for all parameters except f0. Of note, except for a few instances, 
the patient groups and their respective matched-control groups 
had remarkably similar accumulated/averaged measurement 
values (i.e., few statistically significant differences). These results 
replicate previously reported findings that, on average, individu-
als with nodules or polyps do not speak more often, at a differ-
ent vocal intensity, or at a different habitual pitch compared to 
matched individuals with healthy voices (Van Stan et al., 2015b). 
Furthermore, the results provide initial evidence that patients 
with MTD also do not differ in these metrics compared to their 
matched controls (although CPP trended toward being higher in 
the normative group). More sensitive approaches are thus war-
ranted to increase the discriminatory power among the groups, 
and the applications of the next two analysis frameworks yield 
promising, complementary perspectives.
examples of subglottal impedance-Based 
inverse Filtering
The results of both in-laboratory and in-field assessments are 
illustrated for a single normal female subject. The subglottal 
FigUre 5 | illustration of a daily voice use profile for an adult female diagnosed with bilateral vocal fold nodules. Shown are 5-min moving averages of 
the median and 95th percentile of frame-based voice quality measures, along with self-reported ratings of effort, discomfort, and fatigue at the beginning and end of 
day. The daylong histograms of each measure are shown to the right of each time series. The plots below display the occurrence histograms of contiguous voiced 
segments (left) and estimates of speech phrases between breaths (right).
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IBIF yielded estimates of glottal airflow from the neck-surface 
accelerometer for both assessments. Figure  6 shows a direct 
contrast of the glottal airflow estimates from oral airflow and 
neck-surface acceleration for a portion of the Rainbow Passage. 
Both waveforms and derived measures are presented, where it 
can be seen that, although the fit between signals can be adequate, 
the IBIF-based signal is less prone to inverse filtering artifacts 
than its oral airflow-based counterpart. This is due to the more 
stationary underlying dynamic behavior of the subglottal system 
relative to that of the time-varying vocal tract, thus constituting a 
TaBle 4 | group-based mean (sD) of summary statistics of weeklong vocal dose and voice quality measures computed for adult females in the 
phonotraumatic (n = 51) and non-phonotraumatic (n = 20) vocal hyperfunction patient groups and their respective control groups.
summary statistic Phonotraumatic  
controls
Phonotraumatic  
group
non-phonotraumatic  
group
non-phonotraumatic  
controls
Monitoring duration (hh:mm:ss) 81:11:49 (13:13:35) 77:21:43 (15:36:33) 73:44:37 (10:04:12) 78:59:16 (13:50:13)
sPl (dB sPl re 15 cm)
Mean 83.9 (4.6) 85.2 (4.1) 80.1 (6.0) 83.0 (5.2)
SD 12.5 (2.4) 11.8 (1.9) 9.9 (3.1) 11.2 (3.3)
Minimum 62.7 (5.8) 64.5 (4.9) 63.3 (7.0) 64.5 (6.3)
Maximum 104.2 (6.7) 103.5 (5.9) 96.3 (8.3) 101.7 (9.5)
Range 41.4 (8.5) 39.0 (6.7) 33.0 (10.6) 37.2 (11.6)
f0 (hz)
Mode 201.4 (19.1) 197.2 (22.3) 193.8 (31.1) 192.9 (25.7)
SD 89.6 (17.5) 75.3 (17.3) 73.5 (24.9) 70.1 (14.3)
Minimum 170.3 (14.9) 166.7 (17.4) 160.0 (20.5) 163.2 (22.2)
Maximum 440.6 (58.9) 392.4 (65.5) 382.4 (81.4) 374.6 (62.3)
Range 270.3 (55.9) 225.7 (56.7) 222.4 (81.2) 211.4 (49.4)
Phonation time
Cumulative (hh:mm:ss) 7:24:08 (2:33:32) 7:33:45 (2:36:34) 4:25:14 (2:31:57) 5:46:13 (2:16:17)
Normalized (%) 9.2 (2.9) 9.7 (2.6) 6.0 (3.1) 7.3 (2.7)
cycle dose
Cumulative (millions of cycles) 7.121 (2.76) 6.718 (2.495) 3.708 (2.202) 4.814 (1.831)
Normalized (cycles/h) 87,954 (30,508) 85,719 (25,633) 49,892 (26,997) 61,310 (22,241)
Distance dose
Cumulative (m) 26,769 (11,815) 26,689 (10,999) 12,254 (8284) 18,084 (8466)
Normalized (m/h) 330.0 (129.3) 340.7 (112.1) 165.1 (102.4) 228.0 (98.4)
autocorrelation peak
Mean 0.851 (0.018) 0.843 (0.015) 0.827 (0.022) 0.837 (0.014)
SD 0.080 (0.004) 0.079 (0.004) 0.082 (0.007) 0.079 (0.004)
Minimum 0.677 (0.020) 0.672 (0.016) 0.657 (0.024) 0.668 (0.014)
Maximum 0.941 (0.010) 0.934 (0.011) 0.926 (0.014) 0.928 (0.010)
Range 0.263 (0.015) 0.262 (0.014) 0.269 (0.021) 0.260 (0.013)
harmonic spectral tilt (dB/oct)
Mean −14.1 (0.6) −14.4 (0.6) −13.6 (1.1) −14.1 (0.8)
SD 2.4 (0.3) 2.4 (0.2) 2.5 (0.3) 2.4 (0.2)
Minimum −17.8 (0.8) −18.2 (0.8) −17.5 (1.0) −17.8 (1.1)
Maximum −9.9 (0.8) −10.5 (0.6) −9.3 (1.5) −9.8 (1.0)
Range 8.0 (1.0) 7.7 (0.8) 8.2 (1.2) 8.0 (0.8)
lh ratio (dB)
Mean 30.5 (1.1) 30.5 (1.3) 30.1 (1.3) 30.7 (1.5)
SD 4.4 (0.4) 4.5 (0.4) 4.1 (0.5) 4.5 (0.5)
Minimum 24.0 (0.6) 23.8 (0.7) 23.8 (0.5) 24.1 (0.7)
Maximum 38.3 (1.6) 38.6 (1.8) 37.3 (2.1) 38.8 (2.2)
Range 14.3 (1.3) 14.8 (1.3) 13.5 (1.7) 14.7 (1.6)
cPP (dB)
Mean 22.9 (1.0) 23.2 (1.1) 21.4 (2.1) 22.8 (1.1)
SD 4.5 (0.3) 4.4 (0.3) 4.2 (0.5) 4.4 (0.3)
Minimum 15.1 (0.5) 15.3 (0.6) 14.3 (0.8) 14.9 (0.7)
Maximum 29.6 (1.2) 29.7 (1.2) 28.0 (2.3) 29.3 (1.1)
Range 14.5 (1.0) 14.4 (0.9) 13.8 (1.6) 14.4 (1.0)
Statistically significant differences between means are highlighted (p < 0.001). Minimum, maximum, and range are trimmed estimators reporting 5th percentile, 95th percentile, and 
range of the middle 90% of the data, respectively.
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FigUre 6 | Time-varying estimation of measures derived from the 
airflow-derived (black) and accelerometer-derived (red-dashed) glottal 
airflow signal using subglottal impedance-based inverse filtering. 
Trajectories are shown for an adult female with no vocal pathology for the 
difference between the first two harmonic amplitudes (H1-H2), peak-to-peak 
flow (AC Flow), maximum flow declination rate (MFDR), open quotient (OQ), 
speed quotient (SQ), and normalized amplitude quotient (NAQ).
FigUre 7 | exemplary results using subglottal impedance-based 
inverse filtering of a weeklong neck-surface acceleration signal from 
an adult female with a normal voice. Histograms of the maximum flow 
declination rate (MFDR) measure are displayed in physical and logarithmic 
units. The logarithm of MFDR is plotted against sound pressure level (SPL) to 
confirm the expected linear correlation (r = 0.94) and slope (1.13 dB/dB).
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more tractable inverse filtering problem. As a result, the measures 
of vocal function derived from the subglottal IBIF processing 
appear to be more reliable. Improving upon methods for inverse 
filtering of oral airflow in running speech is a current focus of 
research, which would also allow for testing the assumption that 
Q parameters in the IBIF scheme should remain constant in 
continuous speech conditions.
Figure  7 presents histograms of SPL and MFDR derived 
from the weeklong neck-surface acceleration recording. The 
SPL/MFDR relation provides insights on the efficiency in voice 
production, which was found to be 9  dB per MFDR doubling 
in sustained vowels for normal female subjects (6 dB per MFDR 
doubling for male subjects) (Holmberg et al., 1988). It is noted 
in Figure 7 that when a linear scale is used for MFDR, the histo-
gram peak appears skewed to the left. However, when applying a 
logarithmic transform to MFDR (Holmberg et al., 1988, 1995), 
both SPL and MFDR histograms become Gaussian with different 
means and variances. The ambulatory relation provides a slope 
of 1.13 dB/dB, which is similar to the 1.5 dB/dB slope (9 dB per 
MFDR doubling) reported for oral airflow-based inverse filter-
ing features under sustained vowel conditions (Holmberg et al., 
1988). This result is encouraging as it provides initial validation 
for ambulatory MFDR estimation using subglottal IBIF and also 
provides an indication that average behaviors in normal subjects 
could be related to simple sustained vowel tasks in a clinical 
assessment. The relationship warrants further investigation, with 
challenges foreseen for subjects with voice disorders.
classification results Using Machine 
learning
Figure 8 shows that we were able to correctly classify 74 out of 102 
subjects (72.5%) using a threshold of 0.68. Intuitively, this means 
that a subject is predicted to be a patient with phonotraumatic 
vocal hyperfunction if more than 68% of their windows were 
classified similarly to those from the other patients the LASSO 
model was trained on. The mean (SD) of performance across 
the 51 LASSO models was 0.739 (0.274) for AUC, 0.766 (0.204) 
for F-score, 0.739 (0.296) for sensitivity, and 0.767 (0.288) for 
specificity.
Table  5 summarizes the performance of the statistical 
measures in classifying phonotraumatic vocal hyperfunction. 
As shown, subjects with phonotrauma tended to have f0 and 
SPL distributions that were right-shifted from their previous 
values, i.e., an increased Normalized F0 95th percentile and an 
increased Normalized SPL Skew. We contrast this with the vocally 
normal group, which had a right-shifted (non-normalized) SPL 
distribution, i.e., increased SPL Skew. We could interpret the 
right-shifting of Normalized features in subjects with vocal fold 
nodules to mean that they tended to deviate from their baseline 
f0 and SPL as their days progressed, possibly reflecting increased 
difficulty in producing phonation. For the controls, the fact that 
their absolute SPL Skew was increased without a corresponding 
increase to their Normalized distribution suggests that even when 
control subjects exhibited higher SPL ranges, they tended to stay 
within their baseline ranges.
While a majority of subjects were correctly classified in this 
framework, the predicted labels for some subjects are notably 
incorrect. One possible reason the classification is more accurate 
for the patient versus the control group (19 incorrectly labeled 
patients versus 9 incorrectly labeled controls) might stem from 
our strong labeling assumptions. It is likely that not all frames 
(and therefore not all statistical features of 5-min windows) of 
a patient exhibit vocal behavior associated with phonotraumatic 
hyperfunction. This creates a potentially large set of false-positive 
labels that can cause classification bias.
FigUre 8 | classification results on 102 adult female subjects, 51 with vocal fold nodules or polyps and 51 matched-control subjects with normal 
voices. Per-patient unbiased model performance using summary statistics of sound pressure level and fundamental frequency from non-overlapping, 5-min 
windows.
TaBle 5 | association of summary statistics features of sound pressure 
level (sPl) and fundamental frequency (f0) with group label across the 51 
lassO models.
association  
count
Multivariate lassO  
association
summary 
statistic
Patient control Beta  
mean (sD)
Odds ratio mean 
(95% ci)
Normalized SPL 
skew
51 0 1.11 (0.04) 3.03 (2.72–3.69)
Normalized f0 
95th percentile
51 0 0.86 (0.03) 2.36 (2.16–2.70)
f0 skew 51 0 0.53 (0.09) 1.69 (1.42–2.35)
Normalized SPL 
kurtosis
51 0 0.28 (0.02) 1.32 (1.22–1.44)
Normalized SPL 
5th percentile
51 0 0.14 (0.03) 1.16 (1.05–1.30)
Normalized 
percent 
phonation
51 0 0.12 (0.02) 1.13 (1.07–1.20)
Normalized f0 5th 
percentile
0 50 −0.10 (0.02) 0.91 (0.85–1.00)
Normalized SPL 
95th percentile
0 51 −0.17 (0.03) 0.84 (0.77–0.91)
SPL kurtosis 0 51 −0.28 (0.02) 0.76 (0.69–0.82)
Normalized f0 
skew
0 51 −0.41 (0.07) 0.66 (0.51–0.77)
SPL skew 0 51 −2.84 (0.12) 0.06 (0.03–0.08)
The maximum number that the “association count” field can have is 51. This occurs 
when that particular variable (row) has a statistically significant effect (p < 0.001, 
absolute average odds ratios ≥1.10) in each model. Many associations persisted 
across all models and also tended to agree well on the magnitude of the association. 
The 95% confidence interval (CI) is from the lowest bound across subsets to the 
highest bound across subsets.
FigUre 9 | Occurrence histogram of voiced/unvoiced contiguous 
segment pairs. The figure includes the number of times (per hour) that a 
voiced segment of a given duration is followed by an unvoiced segment of a 
given duration.
October 2015 | Volume 3 | Article 15512
Mehta et al. Ambulatory monitoring of voice disorders
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org
DiscUssiOn
An understanding of daily behavior is essential to improving the 
diagnosis and treatment of hyperfunctional voice disorders. Our 
results indicate that supervised machine learning techniques 
have the potential to be used to discriminate patients from 
control subjects with normal voice. It is important to note, how-
ever, that this work did not account for time of day, sequence 
of window occurrence, or ordered loading of features. For an 
example of time-ordered analysis, Figure  9 shows a three-
dimensional distribution showing the occurrence histograms 
of unvoiced segment durations that immediately followed 
successively longer voiced-segment durations over the course 
of a day. This analysis approach attempts to reflect a speaker’s 
vocal behavior in terms of how much voice rest follows bursts 
of voicing activity. Similarly, ongoing monitoring of phona-
tion time after a particular vocal load in a preceding window 
represents additional methods that may lead to complementary 
pieces of information that can aid in the successful detection of 
hyperfunctional vocal behaviors.
The subglottal IBIF measures for continuous speech appear 
more accurate than the oral airflow based due to the additional 
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challenges associated with performing time-varying inverse 
filtering for the vocal tract. Improving upon methods for inverse 
filtering of oral airflow in continuous speech is a current focus 
of research, which would also allow for testing the assumption 
that Q parameters remain constant during speech production. 
The evaluation of subglottal IBIF using weeklong ambulatory 
data acquired with the VHM illustrates that the relation between 
SPL and MFDR is very well aligned with previous observations 
for sustained vowels for adult female subjects (Holmberg et al., 
1988). This result provides initial validation of using IBIF to 
estimate MFDR from the acceleration signal; however, further 
analysis using normative speaker populations and individuals 
with varying voice disorder severity is required.
In order to make the most use of our data without re-using any 
training data in the test set, we trained 51 separate L1-regularized 
logistic regression LASSO models. For a fair comparison of the 
collective performance of these models on test input, we used 
a uniform threshold of 0.5 to classify the output of each 5-min 
window passed through the LASSO model. This created a set 
of predicted binary labels (0, 1) for all windows in any subject’s 
entire record. The proportion of each subject’s windows that are 
classified as a 1 in this process is plotted in Figure 8, ranging from 
0 to 100%. For example, a subject very near the top of the graph 
would have had almost all of their 5-min windows over the course 
of the week classified as a 1. Using this output, we can perform 
inter-model comparisons. In the paper, we report the “optimal 
threshold” (0.68) that created the highest accuracy measure. It is 
possible to improve the sensitivity or specificity of our results by 
lowering or raising this threshold appropriately.
One of the most challenging aspects of voice treatment is 
achieving carryover (long-term retention) of newly established 
vocal behaviors from the clinical setting into the patient’s daily 
environment (Ziegler et al., 2014). Adding biofeedback capabili-
ties to an ambulatory monitor has significant potential to address 
this carryover challenge by providing individuals with timely 
information about their vocal behavior throughout their typi-
cal activities of daily living. Pilot work has shown that speakers 
with normal voices exhibit a biofeedback effect by modifying 
their SPL levels in response to cueing from an ambulatory voice 
monitoring device (Van Stan et al., 2015a). Long-term retention, 
however, was not observed and may require the use of alternative 
biofeedback schedules (e.g., decreasing the frequency and delay-
ing the presentation of biofeedback) that have been well-studied 
in the motor learning literature.
cOnclUsiOn
Wearable voice monitoring systems have the potential to pro-
vide more reliable and objective measures of voice use that can 
enhance the diagnostic and treatment strategies for common 
voice disorders. This report provided an overview of our group’s 
approach to the multilateral characterization and classification 
of common types of voice disorders using a smartphone-based 
ambulatory voice health monitor. Preliminary results illustrate 
the potential for the three analysis approaches studied to help 
improve assessment and treatment for hyperfunctional voice 
disorders. Delineating detrimental vocal behaviors may aid in 
providing real-time biofeedback to a speaker to facilitate the 
adoption of healthier voice production into everyday use.
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